Literature DB >> 2951435

Detergent solubilization of the interleukin 1 receptor.

K A Paganelli, A S Stern, P L Kilian.   

Abstract

Interleukin 1 (IL 1) receptors were solubilized from membranes prepared from murine EL-4 thymoma cells with the zwitterionic detergent 3[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS). Binding of IL 1 to the solubilized receptor was detected by a polyethylene glycol (PEG) precipitation procedure. Concentrations of CHAPS from 4 to 8 mM were effective in solubilizing the IL 1 receptor. At 10 mM CHAPS, there was some loss in binding activity, whereas 2 mM CHAPS was completely ineffective in solubilizing the receptor. Detergent concentrations of 4 mM were routinely used. The solubilized receptor retains the ability to bind 125I-IL 1 in a specific and saturable manner. Scatchard analysis reveals a single type of high affinity binding site having an apparent dissociation constant (KD) of approximately 1.2 X 10(-10) M. Nearly identical KD values are observed for membrane fractions. There are approximately 400 to 500 fmol receptor/mg protein in the detergent extract, corresponding to a two- to threefold enrichment in the Bmax observed for membranes. There is no loss in receptor activity as determined by complete recovery of the total number of binding sites from membranes after solubilization. Binding kinetics show that apparent steady state for the solubilized receptor is reached after 60 min at 37 degrees C. The binding of 125I-IL 1 is essentially irreversible because relatively little bound ligand can be dissociated from the receptor on the addition of excess unlabeled IL 1 at 37 degrees C. Both human IL 1 alpha and IL 1 beta compete for binding of 125I-IL 1 to the soluble receptor, confirming that IL 1 alpha and IL 1 beta bind to the same receptor. Other recombinant proteins, including interferon-alpha A, interferon-gamma, and interleukin 2 have no inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951435

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Two high-affinity interleukin 1 receptors represent separate gene products.

Authors:  R Chizzonite; T Truitt; P L Kilian; A S Stern; P Nunes; K P Parker; K L Kaffka; A O Chua; D K Lugg; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  A novel urinary sialoglycoprotein as the inhibitor of interleukin-1.

Authors:  S Kabir; H Wigzell
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

3.  Interleukin 1 receptor blockade attenuates the host inflammatory response.

Authors:  J E Gershenwald; Y M Fong; T J Fahey; S E Calvano; R Chizzonite; P L Kilian; S F Lowry; L L Moldawer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Human endometrial epithelial cell lines for studying steroid and cytokine actions.

Authors:  S Tabibzadeh; K L Kaffka; P L Kilian; P G Satyaswaroop
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

5.  The usefulness of CHAPS as a non-cytotoxic stabilizing agent in purification of growth factors.

Authors:  Y Matuo; N Nishi; Y Muguruma; Y Yoshitake; Y Masuda; K Nishikawa; F Wada
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

6.  A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.

Authors:  H S Ginsberg; L L Moldawer; P B Sehgal; M Redington; P L Kilian; R M Chanock; G A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  Stabilization of fibroblast growth factors by a non-cytotoxic zwitterionic detergent, 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).

Authors:  Y Matuo; N Nishi; Y Muguruma; Y Yoshitake; Y Masuda; K Nishikawa; F Wada
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

8.  Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; L D Butler
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.

Authors:  E Labriola-Tompkins; C Chandran; K L Kaffka; D Biondi; B J Graves; M Hatada; V S Madison; J Karas; P L Kilian; G Ju
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Regulated export of a secretory protein from the ER of the hepatocyte: a specific binding site retaining C-reactive protein within the ER is downregulated during the acute phase response.

Authors:  S S Macintyre
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.